Literature DB >> 29090665

Quinoxalinone as a Privileged Platform in Drug Development.

Leilei Shi1, Wei Hu2, Jifeng Wu3, Huaiyu Zhou4, Hua Zhou5, Xun Li1.   

Abstract

Among the family of nitrogen-containing heterocycles, quinoxalinone (or quinoxalin-2-one) core, characterized by pyrazin-2(1H)-one fused to benzene ring at two adjacent carbon atoms, has been frequently found in a variety of pharmacologically active compounds with biological or pharmaceutical applications. It was gratifying that a larger part of these bioactive quinoxalinone-based derivatives has entered various clinical trials, which in turn hastens the synthetic versatility and also initiates various derivatization of quinoxalinone scaffold. In this review, we highlighted the newly emerged quinoxalinone- based derivatives or analogues, with the emphasis of their biological applications and structure-activity analysis covering literatures in recent years. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Binding mode; SAR analysis.; biological activities; derivates; quinoxaline; quinoxalinone skeleton

Mesh:

Substances:

Year:  2018        PMID: 29090665     DOI: 10.2174/1389557517666171101111134

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  3 in total

1.  Visible-light-induced aerobic C3-H fluoroalkoxylation of quinoxalin-2(1H)-ones with fluoroalkyl alcohols.

Authors:  Xiaobo Xu; Chengcai Xia; Xiaojun Li; Jian Sun; Liqiang Hao
Journal:  RSC Adv       Date:  2020-01-09       Impact factor: 4.036

2.  Discovery of 3-Arylquinoxaline Derivatives as Potential Anti-Dengue Virus Agents.

Authors:  Chih-Hua Tseng; Cheng-Ruei Han; Kai-Wei Tang
Journal:  Int J Mol Sci       Date:  2019-09-26       Impact factor: 5.923

3.  Synthesis, characterization of two matrine derivatives and their cytotoxic effect on Sf9 cell of Spodoptera frugiperda.

Authors:  Huiqing He; Xiangjing Qin; Fangyun Dong; Jingmin Ye; Chunbao Xu; Hanhui Zhang; Zhanmei Liu; Xiaojing Lv; Yuehua Wu; Xuhong Jiang; Xingan Cheng
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.